Related Experiment Video
Updated: Feb 1, 2026

Development of a Benchtop Model for Evaluating the Compatibility of Wound Dressing Materials with Negative Pressure Wound Therapy Systems
Published on: May 2, 2025
Systemic therapy
1Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. awolff@jhmi.edu
Abstract:
The systemic treatment of breast cancer is a moving target, reflected by the continuous update of treatment guidelines. Chemotherapy regimens, including the adjuvant role of taxanes and preoperative systemic therapy, continue to be optimized. A major challenge facing researchers and clinicians is how to improve the therapeutic index of present and future therapies, identify patients most likely to benefit from the proposed intervention, and avoid treating those who would be exposed to potential toxicities with minimal gain. Anti-estrogens are a prime example of a targeted therapy with a high therapeutic index. Data are now available on aromatase inhibitors in the adjuvant setting and pure antiestrogens in metastatic disease. The role of targeted antihuman epidermal growth factor receptor 2 therapy in the adjuvant setting is being actively investigated, but this is complicated by the inadequate standardization of human epidermal growth factor receptor 2 expression assays used in clinical practice. A long overdue revision of the breast cancer staging system becomes effective in January 2003, bringing it more in line with current standards of care and facilitating data collection for future outcome analysis of therapeutic interventions. These and other important developments since 2001 are examined in this review.
Insights
Systemic breast cancer treatment evolves with updated guidelines, focusing on optimizing chemotherapy and targeted therapies like anti-estrogens. Research aims to improve treatment effectiveness and minimize toxicity for better patient outcomes.
Area of Science:
- Oncology
- Medical Treatment
- Clinical Research
Background:
- Systemic breast cancer treatment is dynamic, necessitating continuous guideline updates.
- Optimizing chemotherapy regimens, including taxanes and neoadjuvant therapy, remains crucial.
- Improving the therapeutic index and patient selection are key challenges in cancer therapy.
Purpose of the Study:
- To review significant advancements in systemic breast cancer treatment since 2001.
- To examine the evolving role of chemotherapy, targeted therapies, and staging systems.
- To discuss strategies for enhancing therapeutic efficacy and minimizing treatment-related toxicities.
Main Methods:
- Review of recent literature and clinical data on breast cancer systemic therapies.
- Analysis of anti-estrogen therapies, including aromatase inhibitors and pure anti-estrogens.
- Evaluation of targeted therapy for human epidermal growth factor receptor 2 (HER2) and its associated diagnostic challenges.
- Assessment of the revised breast cancer staging system and its implications for outcome analysis.
Main Results:
- Anti-estrogens demonstrate a high therapeutic index, with data available for adjuvant and metastatic settings.
- Targeted anti-HER2 therapy is under investigation but hindered by assay standardization issues.
- A revised breast cancer staging system (effective January 2003) aims to align with current standards and improve data collection.
Conclusions:
- Continuous evolution of systemic breast cancer treatment requires ongoing research and guideline updates.
- Personalized medicine approaches, including targeted therapies and improved patient selection, are essential.
- Standardization of diagnostic assays and staging systems are critical for advancing breast cancer care and research.
Related Concept Videos
Gene Therapy
Second Order systems II
First Order Systems
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...
Second Order systems I
By reinterpreting the system, one can derive the closed-loop transfer function, which...
Group Therapy
Thermodynamic Systems
Consider an example of tea boiling in a kettle. The...

